Miles Gerson

Miles joined Takeda Ventures, Inc. (TVI) in April 2020, as a Sr. Partner, and is based in Cambridge, Massachusetts. He currently serves as Board Director or Observer at the Board of four TVI portfolio companies, including Catamaran Bio, Inc., ImmPACT, Bio, Inc., and Carmine Therapeutics, Ltd. Prior to joining TVI, Miles held multiple operational roles spanning founding management, head of finance, head of business development, and head of legal for venture-backed & publicly-traded companies, as well as serving as UCLA’s Managing Officer of Business Development.